| 英文名称 | 中文名称 | CAS | MF |
|
1,1,2,2-tetrakis(4-(pyridin-4-ylethynyl)phenyl)ethene
|
1,1,2,2-四(4-(吡啶-4-基乙炔基)苯基)乙烯
|
2205033-01-6
|
C54H32N4
|
|
PalBociclib Impurity 23
|
PalBociclib Impurity 23
|
2205035-04-5
|
C24H29N7O2
|
|
1-cyclopropyl-7-fluoro-8-methoxy-6-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
|
莫西沙星杂质S
|
2205053-60-5
|
C21H24FN3O4
|
|
4',1'']terphenyl-4-yl-amine
|
4',1'']terphenyl-4-yl-amine
|
2205054-16-4
|
C30H21Br2N
|
|
1-Isobutyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole
|
1-异丁基-3,5-二甲基-4-(4,4,5,5-四甲基-[1,3,2]二氧杂硼环戊烷-2-基)-1H-吡唑
|
2205068-12-6
|
C15H27BN2O2
|
|
TLR7/8-IN-1
|
TLR7/8-IN-1
|
2205095-75-4
|
C29H40N8O2
|
|
3-(4-chlorophenyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
|
3-(4-氯苯基)-6,7-二氢-1H-吡咯并[3,2-C]吡啶-4(5H)-酮
|
2205384-46-7
|
C13H11ClN2O
|
|
Quinazoline, 2,4,6-trichloro-8-fluoro-
|
2,4,6-三氯-8-氟喹唑啉
|
2205387-69-3
|
C8H2Cl3FN2
|
|
1H-Indole, 2-(2,6-dimethyl-4-pyridinyl)-3-(1-methylethyl)-5-(4-piperidinyl)-
|
化合物BMS-905
|
2205846-49-5
|
C23H29N3
|
|
(methanetetrayltetrakis(benzene-4,1-diyl))tetrakis(aminomethaniminium)
|
(methanetetrayltetrakis(benzene-4,1-diyl))tetrakis(aminomethaniminium)
|
2205867-69-0
|
C29H29ClN8
|
|
Ticagrelor Related Compound 65
|
Ticagrelor Related Compound 65
|
2205903-72-4
|
C21H34N6O8S
|
|
Ticagrelor Related Compound 46
|
替格瑞洛杂质46
|
2205903-73-5
|
C28H42ClN9O8S2
|
|
Ticagrelor Related Compound
|
替卡格雷相关化合物
|
2205903-74-6
|
C27H42N6O8S
|
|
Ticagrelor Related Compound 39
|
Ticagrelor Related Compound 39
|
2205903-75-7
|
C34H50ClN9O8S2
|
|
Alogliptin Impurity 14
|
阿格列汀杂质14
|
2205979-07-1
|
C13H10ClN3O2
|
|
Cyclohexanecarboxylic acid, 4-(methylamino)-, hydrochloride (1:1), cis-
|
顺式-4-(甲氨基)环己烷甲酸盐酸盐
|
2206112-18-5
|
C8H15NO2.ClH
|
|
Ethyl 3-(1H-Pyrazol-3-Yl)Indolizine-1-Carboxylate(WX135236)
|
乙基 3-(1H-吡唑-3-基)吲哚嗪-1-甲酸基酯
|
2206113-51-9
|
C14H13N3O2
|
|
Roflumilast Impurity 14
|
罗氟司特杂质14
|
2206113-97-3
|
C17H16F2N2O3
|
|
cis-Hexahydropyrrolo[3,4-c]pyrrol-1(2H)-one hydrochloride
|
顺式八氢吡咯并[3,4-C]吡咯-1-酮盐酸盐
|
2206134-91-8
|
C6H10N2O.ClH
|
|
Levofloxacin Impurity 4
|
左氧氟沙星杂质4
|
2206135-16-0
|
C23H30FN5O3
|
|
Palbociclib-012
|
帕布昔利布标准品012
|
2206135-30-8
|
C41H55N11O5
|
|
Quetiapine iMpurity
|
富马酸喹硫平杂质
|
2206135-48-8
|
C14H11NOS
|
|
Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol]
|
喹硫平杂质
|
2206135-50-2
|
C25H18N2S2
|
|
1-(2-Fluoro-4-methylphenyl)-ethylamine hydrochloride
|
1-(2-氟-4-甲基苯基)乙烷-1-胺盐酸盐
|
2206265-54-3
|
C9H13ClFN
|
|
2,4-Dichloro-6-ethoxyquinazoline
|
2,4-Dichloro-6-ethoxyquinazoline
|
2206320-30-9
|
C10H8Cl2N2O
|
|
Levofloxacin Impurity 5
|
左氧氟沙星杂质5
|
2206360-62-3
|
C13H10FNO5
|
|
Rivaroxaban Impurity 35
|
利伐沙班杂质35
|
2206360-74-7
|
C23H24N4O6
|
|
Rivaroxaban Impurity 49
|
Rivaroxaban Impurity 49
|
2206360-84-9
|
C16H22Cl2N2O4
|
|
di-tert-butyl 1-(3-methylbenzyl)hydrazine-1,2-dicarboxylate*
|
二-叔-丁基 1-(3-甲基苯甲基)肼-1,2-二甲酸基酯
|
2206568-00-3
|
C18H28N2O4
|
|
Aprepitant EP Impurity B
|
Aprepitant EP Impurity B
|
2206606-86-0
|
C29H25F7N4O3
|
|
Ethanol, 2-[2-[4-(5,5-dioxidodibenzo[b,f][1,4]thiazepin-11-yl)-1-oxido-1-piperazinyl]ethoxy]-
|
喹硫平杂质6
|
2206606-97-3
|
C21H25N3O5S
|
|
1-(4-Chloro-2-fluorophenyl)-ethylamine hydrochloride
|
1-(4-Chloro-2-fluorophenyl)-ethylamine hydrochloride
|
2206608-00-4
|
C8H9ClFN.ClH
|
|
(S)-(tetrahydro-2H-pyran-2-yl)methanamine hydrochloride
|
(S)-(四氢-2H-吡喃-2-基)甲胺盐酸盐
|
2206608-25-3
|
C6H14ClNO
|
|
Tert-Butyl2,9-Diazaspiro[5.5]Undecane-9-Carboxylate Oxalate*
|
2,9-二氮杂螺[3-5]叔丁基-9-羧酸叔丁酯草酸盐
|
2206610-58-2
|
C16H28N2O6
|
|
IDT-C8-2CHO
|
IDT-C8-2CHO
|
2206677-82-7
|
C50H74O2S2
|
|
KRas G12C inhibitor 2
|
KRAS G12C INHIBITOR 2
|
2206735-61-5
|
C32H37N7O3
|
|
KRas G12C inhibitor 3
|
KRAS G12C INHIBITOR 3
|
2206735-75-1
|
C32H36ClN7O2
|
|
2-((S)-1-acryloyl-4-(7-(8-methylnaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile
|
MRTX-1257
|
2206736-04-9
|
C33H39N7O2
|
|
Pyrido[3,4-d]pyrimidine-7(6H)-carboxylic acid, 4-[(3S)-3-(cyanomethyl)-4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]-5,8-dihydro-2-(methylthio)-, phenylmethyl ester
|
|
2206737-02-0
|
C27H34N6O4S
|
|
Pyrido[3,4-d]pyrimidine-7(6H)-carboxylic acid, 4-[(3S)-3-(cyanomethyl)-4-[(1,1-dimethylethoxy)carbonyl]-1-piperazinyl]-5,8-dihydro-2-(methylsulfinyl)-, phenylmethyl ester
|
|
2206737-03-1
|
C27H34N6O5S
|
|
1-Piperazinecarboxylic acid, 2-(cyanomethyl)-4-[5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, 1,1-dimethylethyl ester, (2S)-
|
1-Piperazinecarboxylic acid, 2-(cyanomethyl)-4-[5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, 1,1-dimethylethyl ester, (2S)-
|
2206737-05-3
|
C24H37N7O3
|
|
2-Piperazineacetonitrile, 4-[7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, (2S)-
|
2-((S)-4-(7-(8-氯萘-1-基)-2-((((S)-1-甲基吡咯烷-2-基)甲氧基)-5,6,7,8-四氢吡啶基 [3,4-D]嘧啶-4-基)哌嗪-2-基)乙腈
|
2206737-06-4
|
C29H34ClN7O
|
|
2-Pyrrolidinemethanol, 4-fluoro-1-methyl-, (2S,4R)-
|
((2S,4R)-4-氟-1-甲基吡咯烷-2-基)甲醇
|
2206737-78-0
|
C6H12FNO
|
|
Naphthalene, 1-bromo-8-ethyl-
|
1-溴-8-乙基萘
|
2206741-04-8
|
C12H11Br
|
|
2-Piperazinemethanol, 5-methyl-, (2R,5S)-
|
2206741-25-3
|
2206741-25-3
|
C6H14N2O
|
|
1-Piperazinecarboxylic acid, 5-(hydroxymethyl)-2-methyl-, 1,1-dimethylethyl ester, (2S,5R)-
|
2206741-27-5
|
2206741-27-5
|
C11H22N2O3
|
|
4-Bromo-5,6-dimethyl-1H-indazole
|
4-溴-5,6-二甲基-1H-吲唑
|
2206742-47-2
|
C9H9BrN2
|
|
4-Bromo-5,6-dimethyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
|
4-溴-5,6-二甲基-1-(四氢-2H-吡喃-2-基)-1H-吲唑
|
2206742-48-3
|
C14H17BrN2O
|
|
tert-butyl 7-oxo-1-azaspiro[4.4]nonane-1-carboxylate
|
7-氧代-1-氮杂螺[4.4]壬烷-1-羧酸叔丁酯
|
2206825-58-1
|
C13H21NO3
|
|
Apixaban Impurity 44
|
阿哌沙班杂质44
|
2206825-81-0
|
C25H27N5O5
|
|
Apixaban Amino Acid Impurity
|
阿哌沙班氨基酸杂质
|
2206825-87-6
|
C25H27N5O5
|
|
PraMipexole DiMer IMpurity II
|
PraMipexole DiMer IMpurity II
|
2206826-82-4
|
C20H32N6S2
|
|
Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate
|
Sorafenib impurity 16/Ethyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate
|
2206827-12-3
|
C16H17N3O4
|
|
Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate
|
Sorafenib impurity 14/Isopropyl (4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)carbamate
|
2206827-14-5
|
C17H19N3O4
|
|
(3-Iodophenyl)acetic acid tert-butyl ester
|
(3-Iodophenyl)acetic acid tert-butyl ester
|
2206970-15-0
|
C12H15IO2
|
|
(3R)-3-Aminobutan-1-ol hydrochloride
|
(3R)-3-Aminobutan-1-ol hydrochloride
|
2207524-70-5
|
C4H12ClNO
|
|
Ticagrelor Related Compound 93
|
Ticagrelor Related Compound 93
|
2207528-55-8
|
C23H28F2N6O4S
|
|
2,6-Piperidinedione, 3-(1,3-dihydro-4-iodo-1-oxo-2H-isoindol-2-yl)-
|
3-(4-碘-1-氧代异吲哚啉-2-基)哌啶-2,6-二酮
|
2207541-30-6
|
C13H11IN2O3
|
|
QCA570
|
QCA570
|
2207569-08-0
|
C39H33N7O4S
|
|
MPEG11-CH2CH2COONHS
|
MPEG11-CH2CH2COONHS
|
2207596-93-6
|
C30H55NO16
|
|
(3S,3'S)-3,3'-Bis(tert-butyl)-2,2',3,3'-tetrahydro-4,4'-bi-1,3-benzoxaphosphole
|
(3S,3'S)-3,3'-二叔丁基-2,2',3,3'-四氢-4,4'-双-1,3-苯并氧磷杂环戊二烯
|
2207601-04-3
|
C22H28O2P2
|
|
(2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole
|
(2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole
|
2207601-10-1
|
C24H32O2P2
|
|
(2S,2'S,3S,3'S)-3,3'-di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole
|
(2S,2'S,3S,3'S)-3,3'-二叔丁基-2,2'-二异丙基-2,2',3,3'-四氢-4,4'-二苯并[D][ 1,3]氧杂磷杂环戊烯
|
2207601-12-3
|
C28H40O2P2
|
|
5-Azaspiro[2.4]heptane-7-carboxylic acid, methyl ester, hydrochloride (1:1)
|
5-氮杂螺[2.4]庚烷-7-羧酸甲酯盐酸盐
|
2207870-15-1
|
C8H14ClNO2
|
|
1-(4-Methoxy-1-methyl-1H-pyrazol-3-yl)ethanol
|
1-(4-甲氧基-1-甲基-1H-吡唑-3-基)乙醇
|
2207960-17-4
|
C7H12N2O2
|
|
2-Naphthalenecarbonitrile, 5-amino-5,6,7,8-tetrahydro-, hydrochloride (1:1), (5R)-
|
(R)-5-氨基-5,6,7,8-四氢萘-2-甲腈盐酸盐
|
2208138-72-9
|
C11H13ClN2
|
|
Aprepitant EP Impurity C
|
阿瑞匹坦EP杂质C
|
2208275-99-2
|
C29H25F7N4O3
|
|
methyl3-(piperazin-1-yl)benzoatehydrochloride
|
甲基 3-(哌嗪-1-基)苯酸盐盐酸
|
2208746-53-4
|
C12H17ClN2O2
|
|
1-(2-Fluoro-4-methylbenzyl)-piperazine dihydrochloride
|
|
2208779-90-0
|
C12H18ClFN2
|
|
(S)-(-)-Ofloxacin-d3 (N-methyl-d3)
|
(S)-(-)-Ofloxacin-d3 (N-methyl-d3)
|
2208780-63-4
|
C18H20FN3O4
|
|
N,9,9-triphenyl-N-(4'-(triphenylsilyl)-[1,1'-biphenyl]-4-yl)-9H-fluoren-2-amine
|
N,9,9-三苯基-N-(4-(三苯基甲硅烷基)-4-联苯基)芴-2-胺
|
2209040-18-4
|
C61H45NSi
|
|
2,5-phenyl-n, N-bis (4-carboxyphenyl) - [3,2-b] pyrrolopyrrole
|
2,5-苯基-N,N-二(4-羧基苯基)-[3,2-B]吡咯并吡咯
|
2209045-57-6
|
C32H22N2O4
|
|
PDGFRα kinase inhibitor 1
|
PDGFRα kinase inhibitor 1
|
2209053-93-8
|
C34H34N8O2
|
|
(S,E)-Methyl 2-amino-4-(4-fluorophenyl)but-3-enoate HCl
|
(S,E)-METHYL 2-AMINO-4-(4-FLUOROPHENYL)BUT-3-ENOATE HCL
|
2209078-25-9
|
C11H13ClFNO2
|
|
(2'-chloro-[1,1'-biphenyl]-2-yl)boronicacid
|
2-氯-2-硼酸联苯
|
2209082-58-4
|
C12H10BClO2
|
|
JH-XI-10-02
|
JH-XI-10-02
|
2209085-22-1
|
C53H69N5O9
|
|
1-((1S,2S)-2-(diMethylaMino)cyclohexyl)-3-(perfluorophenyl)thiourea
|
1-[(1S,2S)-2-(二甲基氨基)环己基]-3-(五氟苯基)硫脲
|
2209086-92-8
|
C15H18F5N3S
|
|
Bis(6-methylheptyl) Phthalate-3,4,5,6-d4
|
Bis(6-methylheptyl) Phthalate-3,4,5,6-d4
|
2209087-06-7
|
C6D4[COO(CH2)5CH(CH3)2]2
|
|
(2R)-2-[[[[3,5-
Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-
3,3-dimethyl-N-(phenylmethyl)butanamide
|
(2R)-2-[[[[3,5-
Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-
3,3-dimethyl-N-(phenylmethyl)butanamide
|
2209087-17-0
|
C22H23F6N3OS
|
|
Thiophene, 5-bromo-3-fluoro-2-hexyl-
|
Thiophene, 5-bromo-3-fluoro-2-hexyl-
|
2209090-37-7
|
C10H14BrFS
|
|
Stachartone A
|
|
2209109-64-6
|
C46H62O9
|
|
6-(trifluoromethyl)-2-azaspiro[3.3]heptane hydrochloride
|
6-(trifluoromethyl)-2-azaspiro[3.3]heptane hydrochloride
|
2209112-05-8
|
C7H11ClF3N
|
|
Amycolatopsin A
|
AMYCOLATOPSIN A
|
2209112-96-7
|
C60H98O23
|
|
Spiro[benz[c]indeno[2,1-a]carbazole-14(13H),9'-[9H]fluorene]
|
13H-螺[苯并[C]茚并[2,1-A]咔唑-14,9'-芴
|
2209881-38-7
|
C35H21N
|
|
[1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]-
|
[1,1'-Biphenyl]-3-carboxamide, 4'-[[[1-(cyclopropylcarbonyl)-1,2,3,4-tetrahydro-7-quinolinyl]amino]sulfonyl]-
|
2210228-45-6
|
C26H25N3O4S
|
|
Bortezomib Impurity 60
|
Bortezomib Impurity 60
|
2210228-73-0
|
C17H27BF3NO3
|
|
9(10H)-Acridinone, 7-(2-aminoethyl)-1-fluoro-
|
(FREEBASE)
|
2210244-83-8
|
C15H13FN2O
|
|
1,3,2-Dioxaborolane, 2-(2'-chloro[1,1'-biphenyl]-2-yl)-4,4,5,5-tetramethyl-
|
1,3,2-Dioxaborolane, 2-(2'-chloro[1,1'-biphenyl]-2-yl)-4,4,5,5-tetramethyl-
|
2210254-25-2
|
C18H20BClO2
|
|
(2-chloronaphthalen-1-yl)boronic acid
|
B-(2-Chloro-1-naphthalenyl)boronic acid
|
2210262-72-7
|
C10H8BClO2
|
|
β-Alanine, N-[6-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-1-oxohexyl]-N-2-propyn-1-yl-, 1,1-dimethylethyl ester, rel-
|
|
2210266-88-7
|
C25H34N2O5
|
|
β-Alanine, N-[6-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-1-oxohexyl]-N-2-propyn-1-yl-, 2,5-dioxo-1-pyrrolidinyl ester, rel-
|
|
2210266-91-2
|
C25H29N3O7
|
|
Macitentan Impurity 16
|
马西替坦杂质16
|
2211054-17-8
|
C12H10BrN3O
|
|
4(3H)-Pyrimidinone, 6-amino-5-(4-bromophenyl)-
|
马昔腾坦杂质QTH
|
2211054-46-3
|
C10H8BrN3O
|
|
Macitentan Impurity 2
|
Macitentan Impurity 2
|
2211054-90-7
|
C10H8Br2N4O2
|
|
4-Pyrimidinamine, 5-(4-bromophenyl)-6-chloro-
|
中间体
|
2211057-81-5
|
C10H7BrClN3
|
|
N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide
|
N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide
|
2211059-00-4
|
C19H21BrN6O4S
|
|
Macitentan Hydroxy amine Impurity
|
Macitentan Hydroxy amine Impurity
|
2211059-05-9
|
C12H12BrN3O2
|
|
Acotiamide Impurity 21
|
Acotiamide Impurity 21
|
2211097-75-3
|
C8H6N4O3S2
|
|
Thiol-PEG12-acid
|
Thiol-PEG12-acid
|
2211174-73-9
|
C27H54O14S
|
|
IN1371, 2-(2-ethylhexyl)-5,6-difluoro-2H-benzo[d][1,2,3]triazole
|
2-(2-乙基己基)-5,6-二氟-2H-苯并[D][1,2,3]三唑
|
2211181-64-3
|
C14H19F2N3
|